Currently, the only established therapeutic option for end-stage liver disease is orthotopic liver transplantation. However, the paucity of donor organs limits this option to only a few patients. From liver stem cells to advanced tissue bioengineering, this episode of EASL Studio discusses regenerative hepatology techniques as an alternative treatment for patients.


  • Prof. Pedro Baptista (Moderator)
  • Prof. Tobias Cantz (Faculty)
  • Prof. Karen Piper Hanley (Faculty)
  • Prof. Frederic Lemaigre (Faculty)

Related episode:

Listen to the podcast


This podcast is also available on the following platforms:

spotify      Amazon music      Apple